Related Experiment Videos
Verapamil induced gingival enlargement in cluster headache
M S Matharu1, J A van Vliet, M D Ferrari
1Headache Group, Institute of Neurology, Queen Square, London WC1N 3BG, UK. peterg@ion.ucl.ac.uk
Journal of Neurology, Neurosurgery, and Psychiatry
|December 21, 2004
Summary
Verapamil, used for cluster headaches, can cause gingival enlargement. This side effect is often reversible with improved dental hygiene and may require dose adjustment or discontinuation of verapamil.
Area of Science:
- Neurology
- Pharmacology
- Dentistry
Background:
- Verapamil is a commonly prescribed medication for prophylactic treatment of cluster headaches.
- Its efficacy in headache management is well-established, leading to widespread clinical use.
Observation:
- This report details four cases of cluster headache patients experiencing gingival enlargement following verapamil initiation.
- The observed side effect specifically targets the gingival tissues.
Findings:
- Two patients managed gingival enlargement effectively through enhanced oral hygiene and dental plaque control.
- Two other patients required a reduced verapamil dosage alongside rigorous oral hygiene to resolve the enlargement.
- Complete cessation of verapamil was necessary in one case to reverse the gingival enlargement.
Implications:
- Healthcare providers prescribing verapamil for cluster headaches must monitor for gingival enlargement.
- Early intervention with dental hygiene practices can prevent or manage this verapamil-induced side effect.
- Reversibility through medication adjustment or discontinuation highlights the importance of patient-physician-dentist communication.